IPBronch.com | Interventional Pulmonology

🎯 Background & Rationale

Balloon tracheobronchial dilation is a primary therapeutic modality for managing central airway obstruction (CAO) and extrinsic airway compression. However, conventional dilating balloons completely occlude the airway lumen during inflation. This forces periods of patient apnea, limits the safe duration of individual dilation cycles, and restricts overall procedure time—posing significant risks, particularly in patients with marginal cardiopulmonary reserve and severe baseline hypoxemia. Nonocclusive balloon dilators (such as the Trachealator) are designed to overcome this by maintaining a central open channel for continuous ventilation and oxygenation throughout inflation. This study evaluates the clinical outcomes, technical considerations, and safety profile of nonocclusive balloon dilation in severe tracheobronchial stenosis.

👥 Study Design & Population

This is a retrospective, cross-sectional observational case series conducted at a tertiary care center (La Fe University and Polytechnic Hospital, Valencia, Spain). The cohort comprised 11 patients who underwent a total of 16 procedures for central airway stenosis (trachea and/or main bronchi).

Demographics: Mean age of 55 ± 23 years (ranging from pediatric to geriatric patients, 13 to 78 years); 55% female.
Pathology: 54.5% of stenoses were of malignant etiology (pulmonary neoplasms and lymphoproliferative syndrome), while 45.5% were benign (post-radiotherapy, idiopathic, schwannoma, and post-tuberculosis).
Stenosis Characteristics: Median airway narrowing severity was 83% (IQR: 70% to 94%). Most stenoses involved the trachea (72.7%), with mixed intrinsic/extrinsic features being the most common presentation.

📈 Methodology & Rigor

Procedures were performed under general anesthesia by experienced interventional pulmonologists using either rigid bronchoscopy (75%) or a supraglottic laryngeal mask airway (25%) in parallel with a therapeutic flexible video bronchoscope. Pre-procedural CT imaging was used for sizing, and radiopaque contrast was utilized for real-time fluoroscopic guidance.

Data Collection: Demographic variables, stenosis features, airway access type, balloon sizes, dilation cycles and durations, concomitant interventions, and oxygenation parameters were systematically tracked.
Statistical Analysis: Continuous variables were assessed for normality and expressed as means ± standard deviations or medians with interquartile ranges. Pre- and post-procedure oxygen saturations were compared using appropriate parametric/non-parametric tests via SPSS.

🔬 Key Findings [or Planned Endpoints]

Ventilation & Oxygenation: The mean minimum oxygen saturation during the procedure was 96.1% ± 3.6%, which significantly increased to a mean final saturation of 98.6% ± 0.8% at the conclusion of the intervention ($P = 0.009$). No procedures were aborted due to hypoxemia or oxygenation failure.
Procedural Parameters: Most procedures (87.5%) utilized 3 consecutive dilation cycles (typically 45 seconds each, with one lasting 240 seconds). In 2 cases, a single, prolonged dilation cycle was performed lasting 300 and 600 seconds, respectively, without complications.
Interventions & Complications: Airway stents were deployed in 38% of procedures (all malignant). Mild, non-balloon-related bleeding occurred in 2 patients (13%), which was attributed to concurrent laser therapy or electrocautery rather than the nonocclusive balloon itself. No dilation-related complications (such as severe airway tears or pneumothorax) were reported.

⚖️ Critical Appraisal

As a retrospective case series without a control group, this study is inherently limited by a small sample size, heterogeneous pathologies, and the presence of significant patient comorbidities. Direct comparisons to occlusive balloons were not ethically or clinically feasible in these high-risk patients due to the unacceptable risk of acute anoxia. Furthermore, the short-term follow-up restricts conclusions regarding long-term patency or recurrence rates. Despite these limitations, the study successfully highlights the real-world technical feasibility and safety of eliminating apnea times during critical airway dilations.

💡 The Clinical Bottom Line

Nonocclusive balloon dilation is a valuable, safe, and physiologically favorable technique for managing severe central airway stenosis. By preserving continuous ventilation and gas exchange throughout inflation, it eliminates the necessity of apnea, protects patients with marginal cardiopulmonary reserve from rapid desaturation, and safely permits extended dilation times. Interventional pulmonologists should consider this modality for high-risk patients with critical central airway obstructions to enhance procedural safety and stability.

BACKGROUND: Balloon tracheobronchial dilation is a key technique for managing central airway stenosis. Conventional occlusive balloons interrupt ventilation and oxygenation, limiting the duration and safety of dilation. The objective of this study was to evaluate the clinical outcomes of tracheobronchial stenosis dilation using a nonocclusive balloon and to describe relevant technical aspects of its application. METHODS: A retrospective cross‑sectional study was conducted, including all patients with central airway stenosis who underwent dilation with a nonocclusive balloon at a tertiary center. In all cases, stenosis severity was ≥50%, confirmed by endoscopic or tomographic assessment, and associated with compatible symptoms. Demographic characteristics, stenosis features, procedural details, oxygenation parameters, and complications were collected. RESULTS: Sixteen procedures were performed in 11 patients; 6 stenoses (54.5%) were malignant. The trachea was the most frequent location (n=8; 72.7%). The median stenosis severity was 83%. The mean minimum oxygen saturation during the procedure was 96.1%±3.6%, increasing to 98.6%±0.8% at the end of the procedure (P=0.009). Most procedures (n=14; 87.5%) included 3 consecutive dilation cycles. In 2 cases (12.5%), a single prolonged cycle was performed, lasting 300 and 600 seconds, respectively. Airway stents were placed in 6 procedures (38%), all in malignant stenosis. Mild complications occurred in 2 patients (13%), consisting of minor or moderate bleeding, not related to balloon dilation. CONCLUSION: Nonocclusive balloon dilation provides effective treatment of tracheobronchial stenosis while maintaining ventilation and oxygenation. This technique enables longer, safer dilation cycles by eliminating the need for apnea.